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Background: Previous reports have suggested that both ceftriaxone and ceftazidime are effective as 
prophylactic perioperative antibiotics in neurosurgery. This study was designed to compare the 
infection rates following the use of these antibiotics as prophylactic agents during neurological surgery 
in our centre. In a tertiary hospital 
Methods: This was a prospective study in which patients were allocated into two groups. One group 
received ceftriaxone (Roche-rocephine) and the other group received ceftazidime (GlaxoSmithKline – 
fortum). Patients were followed up for evidence of surgical site infections for up to 6 weeks after 
discharge. Clinical and or laboratory evidence of wound infection were used as outcome measure. 
Results: There were 118 patients, 58 patients received ceftriaxone and 60 patients received 
ceftazidime. Infection occurred in 4 (6.9%) in the ceftriaxone group and in 9 (15%) in the ceftazidime 
group. The difference was not statistically significant. The infection rate following 
ventriculoperitoneal (VP) shunting procedure was similar (11.8%) in both groups. 
Conclusion: Our study confirmed the efficacy of ceftriaxone and ceftazidime in preventing surgical 
site infection that may follow neurosurgical procedures, but the difference in infection rates following 




Ceftriaxone and ceftazidime are both potent 
antibiotics belonging to the third generation of 
cephalosporins. They have broad spectrum 
activities against gram-positive and gram-
negative microbes. Although the choice of 
prophylactic antibiotics for neurosurgical 
procedures is not fully established as several 
regimen have been used1-6, the morbidity and 
mortality that often accompanies postoperative 
intracranial infections have compelled us to 
consider these antimicrobials as prophylactic 
antibiotics in our centre. In addition, we have 
observed higher infection rate in other previously 
used antimicrobial agents. Previous reports have 
also demonstrated the use of these agents in 
neurosurgical operations7-10. In this study we 
compared the infection rates in our patients who 
received either ceftriaxone or ceftazidime as 
prophylactic perioperative antibiotics. 
 
Patients and Method 
 
This prospective study was carried out between 
September 1998 and December 1999. 
Consecutive patients were allotted into two 
groups; Group I received intravenous ceftriaxone 
(Roche - Rocephine) 100mg/kg daily for two days 
while Group II received intravenous ceftazidime 
(GlaxoSmithKline – fortum) 50mg/kg every 
twelve hours for two days. The first dose of 
antibiotics was given at induction of anaesthesia. 
We also used irrigation fluid containing 40mg of 
Gentamycin in 500 ml of normal saline in all the 
patients. Patients who had evidence of intracranial 
or scalp infection and those on antibiotics before 
surgery, were excluded from the study.  
 
Clinical and/or laboratory evidence of wound 
infection or intracranial infection was used as 
outcome measures. The patients were followed up 
in the ward and in the clinic for six weeks. We 
analyzed the presence or absence of wound 
infection, demographic data, diagnosis and type 
of surgical procedure. The statistical significance 
of the difference in infection rates in the two 
groups was determined by Chi-square. The p-





There were a total of one hundred and eighteen 
patients. Fifty eight patients received ceftriaxone 
and sixty patients received ceftazidime. The age 
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Table 1. List of operations  
 
 Procedure Frequency % Valid % Cumulative % 
 
VP Shunt 34 28.8 28.8 28.8 
Repair of Encephalocoele 1 0.8 0.8 29.7 
Craniotomy & Excision of Tumour 12 10.2 10.2 39.8 
Suboccipital Craniectomy &Tumour Excision 6 5.1 5.1 44.9 
Cranioplasty 2 1.7 1.7 46.6 
Craniotomy & Lobectomy 3 2.5 2.5 49.2 
Craniotomy & Clot Evacuation 3 2.5 2.5 51.7 
Wound Debridement & Elevation of Fracture 12 10.2 10.2 61.9 
Craniotomy & Clipping Of Aneurysm 1 0.8 0.8 62.7 
Burr Hole &Drainage Of Haematoma 22 18.6 18.6 81.4 
Craniotomy& Drainage Of Abscess 2 1.7 1.7 83.1 
Laminectomy 5 4.2 4.2 87.3 
Repair Of Myelomeningocele 10 8.5 8.5 95.8 
Laminectomy & Excision Of Tumor 5 4.2 4.2 100.0 
Total 118 100.0 100.0  
 
        Table 2. Outcome in Patients Who Had Ceftriaxone as Prophylactic Antimicrobial 
 







VP Shunt 2 15 17 
Repair Of Encephalocele  1 1 
Craniotomy & Excision Of Tumor  2 2 
Wound Debridement And Elevation 
Of Fracture 
 6 6 
Craniotomy&Clipping Of 
Aneurysm 
 1 1 
Burr Hole & Drainage Of 
Haematoma 
 1 1 
Laminectomy 1 4 5 
Repair Of Myelomeningocele 1 8 9 
Laminectomy & Excision Of Tumor  3 3 
Total 4 54 58 
 
Table 1 shows the various procedures performed 
during the study period. Ventriculoperitoneal 
(VP) shunt for hydrocephalus was the most 
common procedure performed with a frequency 
of 38 (28.8%). Only 1 patient had craniotomy and 
clipping of aneurysm. Table 2 shows procedures 
in which ceftriaxone were used in the irrigation 
fluid. VP shunt for hydrocephalus was the most 
common procedure followed by burr hole 
drainage of subacute and chronic subdural 
haematoma. Infection occurred in four procedures 
in this group. Two out of these were in the 
patients who had VP shunt. The overall infection  
 
 
rate was 6.9%. The infection rate in VP shunt 
procedures was 11.8%. 
 
Table 3 shows the procedure in which ceftazidime 
was used. The pattern is similar to table 2 with 
VP shunt for hydrocephalus being the most 
common procedure followed by burr hole 
drainage of subacute and chronic subdural 
haematoma. Nine patients had infection with 
infection rate of 15%. Two of the 17 patients who 
had VP shunts had infection as in the ceftazidime 
group. The infection rate in VP shunt procedure 
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Table 3. Outcome in Patients Who Had Ceftaziime as Prophylactic Antimicrobial 
 






VP Shunt 2 15 17 
Craniotomy And Excision of Tumor 3 7 10 
Suboccipital Craniectomy And Tumour 
Excision 
2 4 6 
CRANIOPLASTY  2 2 
Craniotomy and Lobectomy  3 3 
Craniotomy and Clot Evacuation  1 1 
Wound Debridement & Elevation of 
Fracture 
1 5 6 
Burr Hole &Drainage of Haematoma  11 11 
Craniotomy& Drainage of Abscess  1 1 
Repair Of Myelomeningocele 1  1 
Laminectomy & Excision of Tumor  2 2 
Total 9 51 60 
 
Table 4. Relationship between Patients with and Without Postoperative Infections in the Two Groups. 
 
Group Number of patients with 
infection 
Number of patients 
without infections 
Total number of Patients 
Ceftriaxone group 4 54 58 
Ceftazidime group 9 51 60 
Total 13 105 118 
 
X2 = 1.975, df 1; p=0.160 
 
There were 9 patients with infection in 
ceftazidime group compared to 4 patients in the 
ceftriaxone group but this was not found to be 




The study was carried out in a wide range of 
neurosurgical procedures. The infection rates are 
quite high compare to infection rate reported from 
other parts of the world1,2,4,5,6,11,12. This may be 
related to many factors including poor patients’ 
personal hygiene and inadequate sterilization of 
the instruments, theatre gown and drapes due to 
imperfect sterilization techniques. These are 
peculiar problems of the developing world. 
Improvement of these various factors will 
certainly help to improve the infection rate in our 
neurosurgical procedures. Surprisingly, the 
infection rate following our VP shunt procedure is 
comparable to reports from other parts of the 
world13. This may be related to the short duration 
of follow up in our series or perhaps because of 
the greater attention to meticulous aseptic 
techniques during VP shunt procedure. 
The overall infection rate was higher in 
ceftazidime group (15%) compared to ceftriaxone 
group (6.9%). This difference was, however, not 
statistically      significantly. Furthermore, the 
infection rate in VP shunt procedure was the same 
in both groups with a value of 11.8%. This result 
is not surprising because both drugs are third 
generation cephalosporin with similar 
mechanisms of action. Their spectrum of activity 
is also fairly the same. In addition, the two 
antimicrobials have been found to be effective as 
prophylactic agents in neurosurgical procedures1, 
3, 7-11, 14-16  
 
The total cost for our regime for ceftriaxone is 
N7800 or 54 USD and N11500 or 82 USD for 
ceftazidime. If the inconvenience of double 
dosing, the cost of injection materials and nursing 
time is added to the cost, ceftazidime will be more 
expensive than ceftriaxone. This will suggest that 
ceftriaxone will be a better choice of antibiotic as 
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course of the study, we discovered that there were 
about eight brands of ceftriaxone in the drug 
market in Nigeria. The efficacy of these is 
difficult to ascertain using the present study 
because we restricted the brand used to Roche 
rocephin. Our study confirmed the use of 
ceftriaxone and ceftazidime in preventing surgical 
site infection in neurosurgical procedures. There 
was no statistical significance in the different 
infection rates for both antibiotics. The infection 
rates were similar for both antibiotics following 
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